相关实验视频

Updated: Jun 6, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

精密瘤学:2024年在审查中

Matteo Repetto¹, Nicole Fernandez², Alexander Drilon^1,3

¹Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer discovery

|December 2, 2024

概括

2024年的精密瘤学正在迅速发展. 关键的发展包括使用预测性分子标记物进行更好的患者选择,并通过合理的药物设计和重新定位改进组合疗法.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
药理学药理学是指药理学的学科.

背景情况:

精准瘤学旨在为个别患者量身定制癌症治疗.
识别预测性分子事件对于有效的患者选择至关重要.
药物开发方面的进展对于改善治疗结果至关重要.

研究的目的:

总结2024年精密瘤学的关键进展.
要突出基于分子标记的患者选择的不断发展的策略.
讨论组合疗法,小分子抑制剂设计和药物重用方面的进展.

主要方法:

精确瘤学最新文献和临床试验数据的综述.
对新兴的预测性分子生物标志物的分析.
评估新的治疗策略,包括组合疗法和药物设计.

主要成果:

在识别和利用用于患者分层的预测分子事件方面取得了重大进展.
发展战略组合疗法的进展.
针对小分子抑制剂和结构知情药物重新定位的合理药物设计的创新.

结论:

精密瘤学继续发展,在2024年取得重大进展.
改进的分子分析提高了针对性治疗的患者选择.
新型药物开发和重定向策略有望提供更有效的癌症治疗方法.

更多相关视频

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...